|Articles|October 12, 2012
Trading Away the Medicines of Tomorrow
Author(s)Mike Hennessy
Advertisement
One of the major issues being negotiated right now the amount of protection for the intellectual property of pharmaceutical and biotech companies. And failure to protect the intellectual property rights will actually hurt patients more than the companies.
Click
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Medical Economics
1
Medical AI scores high on exams but stumbles on real patient care, new benchmark finds
2
G2211: A half step that leaves independent primary care behind
3
Most clinicians say U.S. health care is less stable than two years ago
4
Why specialists are the key players in the next phase of value-based care
5